Literature DB >> 27439627

Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Louise E See Hoe1,2, Lauren T May3, John P Headrick1, Jason N Peart4.   

Abstract

Disruption of the sarcolemmal membrane is a defining feature of oncotic death in cardiac ischaemia-reperfusion (I-R), and its molecular makeup not only fundamentally governs this process but also affects multiple determinants of both myocardial I-R injury and responsiveness to cardioprotective stimuli. Beyond the influences of membrane lipids on the cytoprotective (and death) receptors intimately embedded within this bilayer, myocardial ionic homeostasis, substrate metabolism, intercellular communication and electrical conduction are all sensitive to sarcolemmal makeup, and critical to outcomes from I-R. As will be outlined in this review, these crucial sarcolemmal dependencies may underlie not only the negative effects of age and common co-morbidities on myocardial ischaemic tolerance but also the on-going challenge of implementing efficacious cardioprotection in patients suffering accidental or surgically induced I-R. We review evidence for the involvement of sarcolemmal makeup changes in the impairment of stress-resistance and cardioprotection observed with ageing and highly prevalent co-morbid conditions including diabetes and hypercholesterolaemia. A greater understanding of membrane changes with age/disease, and the inter-dependences of ischaemic tolerance and cardioprotection on sarcolemmal makeup, can facilitate the development of strategies to preserve membrane integrity and cell viability, and advance the challenging goal of implementing efficacious 'cardioprotection' in clinically relevant patient cohorts. Linked Articles This article is part of a themed section on Molecular Pharmacology of G Protein-Coupled Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.20/issuetoc.
© 2016 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2016        PMID: 27439627      PMCID: PMC6400434          DOI: 10.1111/bph.13552

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  389 in total

1.  Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation.

Authors:  A Blair; P W Shaul; I S Yuhanna; P A Conrad; E J Smart
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

2.  Effect of aging on plasma membrane fluidity of rat aortic endothelial cells.

Authors:  M Hashimoto; S Hossain; S Masumura
Journal:  Exp Gerontol       Date:  1999-08       Impact factor: 4.032

3.  Beneficial effects of omega-3 fatty acid treatment on the recovery of cardiac function after cold storage of hyperlipidemic rats.

Authors:  K Ku; H Oku; T Kaneda; M Onoe; Z Zhang
Journal:  Metabolism       Date:  1999-10       Impact factor: 8.694

4.  Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction.

Authors:  Y Ueda; M Kitakaze; K Komamura; T Minamino; H Asanuma; H Sato; T Kuzuya; H Takeda; M Hori
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

Review 5.  Abnormalities of membrane function and lipid metabolism in hypertension: a review.

Authors:  J Zicha; J Kunes; M A Devynck
Journal:  Am J Hypertens       Date:  1999-03       Impact factor: 2.689

6.  Effects of hypercholesterolemia on myocardial ischemia-reperfusion injury in LDL receptor-deficient mice.

Authors:  W G Girod; S P Jones; N Sieber; T Y Aw; D J Lefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-11       Impact factor: 8.311

7.  Nitric oxide modulates beta(2)-adrenergic receptor palmitoylation and signaling.

Authors:  L Adam; M Bouvier; T L Jones
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

8.  Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase.

Authors:  O Feron; C Dessy; S Moniotte; J P Desager; J L Balligand
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

9.  Selective regulation of G protein-coupled receptor-mediated signaling by G protein-coupled receptor kinase 2 in FRTL-5 cells: analysis of thyrotropin, alpha(1B)-adrenergic, and A(1) adenosine receptor-mediated responses.

Authors:  L Iacovelli; R Franchetti; D Grisolia; A De Blasi
Journal:  Mol Pharmacol       Date:  1999-08       Impact factor: 4.436

10.  Association of age-related decrease in platelet membrane fluidity with platelet lipid peroxide.

Authors:  M S Hossain; M Hashimoto; S Gamoh; S Masumura
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

View more
  4 in total

1.  Molecular pharmacology of G protein-coupled receptors.

Authors:  R J Summers
Journal:  Br J Pharmacol       Date:  2016-10       Impact factor: 8.739

Review 2.  Cardiac Muscle Membrane Stabilization in Myocardial Reperfusion Injury.

Authors:  Evelyne M Houang; Jason Bartos; Benjamin J Hackel; Timothy P Lodge; Demetris Yannopoulos; Frank S Bates; Joseph M Metzger
Journal:  JACC Basic Transl Sci       Date:  2019-04-29

3.  Dietary α-Linolenic Acid Counters Cardioprotective Dysfunction in Diabetic Mice: Unconventional PUFA Protection.

Authors:  Jake S Russell; Tia A Griffith; Saba Naghipour; Jelena Vider; Eugene F Du Toit; Hemal H Patel; Jason N Peart; John P Headrick
Journal:  Nutrients       Date:  2020-09-02       Impact factor: 5.717

Review 4.  Conditioning-induced cardioprotection: Aging as a confounding factor.

Authors:  Puneet Kaur Randhawa; Anjana Bali; Jasleen Kaur Virdi; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2018-08-27       Impact factor: 2.016

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.